Multiple headlines revolve around the stock performance and strategic moves of Steris Plc (STE). Blue Trust Inc., Foster Victor Wealth Advisors LLC, ORG Partners LLC, and Cwm LLC, among others, have increased their stake in Steris. However, some Insider Selling was reported, with Director Christopher S. Holland and SVP and President, Healthcare Cary Majors, selling portions of their shares.
Steris' recent Q4 2024 and Q1 2025 Earnings Calls were other points of discussion. STERIS' Q1 Earnings beat estimates while operating margin fell. Anticipation builds around the company’s projected Q1 2025 earnings predicted at $2.01 per share by Zacks Research.
The recent SWOT analysis of Steris garnered attention. Investors are keen about Steris’ Q4 earnings and international revenue trends. The company enjoyed robust Q3 Fiscal 2024 results with revenue and earnings growth, and hit a new 1-Year high at $242.70.
However, the stock also reportedly underperformed against its competitors. Lastly, Steris has been focusing on business restructuring, recently selling its dental unit to HuFriedy and announcing layoffs.
Steris Plc STE News Analytics from Thu, 11 Nov 2021 08:00:00 GMT to Sun, 18 Aug 2024 13:41:04 GMT - Rating 7 - Innovation 6 - Information 8 - Rumor -2
